Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Bleoprim
Dosage Form : Bleomycin 15.000Iu 1 Unit Parenteral Use
Dosage Strength : 1 injector vial 15 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
22
PharmaCompass offers a list of Bleomycin Sulphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bleomycin Sulphate manufacturer or Bleomycin Sulphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bleomycin Sulphate manufacturer or Bleomycin Sulphate supplier.
A Bleomycin sulfate [Bleomycins] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bleomycin sulfate [Bleomycins], including repackagers and relabelers. The FDA regulates Bleomycin sulfate [Bleomycins] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bleomycin sulfate [Bleomycins] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bleomycin sulfate [Bleomycins] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Bleomycin sulfate [Bleomycins] supplier is an individual or a company that provides Bleomycin sulfate [Bleomycins] active pharmaceutical ingredient (API) or Bleomycin sulfate [Bleomycins] finished formulations upon request. The Bleomycin sulfate [Bleomycins] suppliers may include Bleomycin sulfate [Bleomycins] API manufacturers, exporters, distributors and traders.
click here to find a list of Bleomycin sulfate [Bleomycins] suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Bleomycin sulfate [Bleomycins] DMF (Drug Master File) is a document detailing the whole manufacturing process of Bleomycin sulfate [Bleomycins] active pharmaceutical ingredient (API) in detail. Different forms of Bleomycin sulfate [Bleomycins] DMFs exist exist since differing nations have different regulations, such as Bleomycin sulfate [Bleomycins] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bleomycin sulfate [Bleomycins] DMF submitted to regulatory agencies in the US is known as a USDMF. Bleomycin sulfate [Bleomycins] USDMF includes data on Bleomycin sulfate [Bleomycins]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bleomycin sulfate [Bleomycins] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bleomycin sulfate [Bleomycins] suppliers with USDMF on PharmaCompass.
A Bleomycin sulfate [Bleomycins] CEP of the European Pharmacopoeia monograph is often referred to as a Bleomycin sulfate [Bleomycins] Certificate of Suitability (COS). The purpose of a Bleomycin sulfate [Bleomycins] CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bleomycin sulfate [Bleomycins] EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bleomycin sulfate [Bleomycins] to their clients by showing that a Bleomycin sulfate [Bleomycins] CEP has been issued for it. The manufacturer submits a Bleomycin sulfate [Bleomycins] CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bleomycin sulfate [Bleomycins] CEP holder for the record. Additionally, the data presented in the Bleomycin sulfate [Bleomycins] CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bleomycin sulfate [Bleomycins] DMF.
A Bleomycin sulfate [Bleomycins] CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bleomycin sulfate [Bleomycins] CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bleomycin sulfate [Bleomycins] suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bleomycin sulfate [Bleomycins] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bleomycin sulfate [Bleomycins] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bleomycin sulfate [Bleomycins] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bleomycin sulfate [Bleomycins] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bleomycin sulfate [Bleomycins] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bleomycin sulfate [Bleomycins] suppliers with NDC on PharmaCompass.
Bleomycin sulfate [Bleomycins] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bleomycin sulfate [Bleomycins] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bleomycin sulfate [Bleomycins] GMP manufacturer or Bleomycin sulfate [Bleomycins] GMP API supplier for your needs.
A Bleomycin sulfate [Bleomycins] CoA (Certificate of Analysis) is a formal document that attests to Bleomycin sulfate [Bleomycins]'s compliance with Bleomycin sulfate [Bleomycins] specifications and serves as a tool for batch-level quality control.
Bleomycin sulfate [Bleomycins] CoA mostly includes findings from lab analyses of a specific batch. For each Bleomycin sulfate [Bleomycins] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bleomycin sulfate [Bleomycins] may be tested according to a variety of international standards, such as European Pharmacopoeia (Bleomycin sulfate [Bleomycins] EP), Bleomycin sulfate [Bleomycins] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bleomycin sulfate [Bleomycins] USP).
